The global vascular stent market accounted to USD 11.8 billion in 2016 growing at a CAGR of 7.90%during the forecast period of 2017 to 2024. The upcoming market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
The vascular stent helps in preventing blood vessel blockages that may happen in individuals who have experienced angioplasty. It keeps up the patency of stenotic vessels and avoids re-blockage because of blood aggregation or excess tissue development. It helps in the treatment of individuals with heart diseases such asperipheral vascular diseases and coronary heart.
- Increase in angioplasty treatment
- Growing technological advancements in stents
- Rising demand of non-invasive techniques
- Increasing aging population
- Alternative methods of treating cardiac diseases
- High cost of vascular stent
On the basis of the types, global vascular stent market is segmented into BMS, BUS and drug eluting.
On the basis of the product, global vascular stent market is segmented into coronary, peripheral, carotid, femoral and aortic aneurysm. In 2016, coronary stents segment accounted the largest market share due to growing technological advancement and rising incidence of coronary artery disease.
On the basis of material, global vascular stent market is segmented into metals and polymers where metals are sub segmented into stainless steel, PtCr and nitinol.
On the basis of end users, global vascular stent market is segmented into hospitals, cardiology centre, and ASC.
The global vascular stent market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes continuous manufacturing market shares for global, Europe, North America, Asia Pacific, and South America.
Major Market Competitors:
Some of the major players of global vascular stent market are Abbott, MEDTRONIC, B. Braun Melsungen AG, TERUMO CORPORATION, Boston Scientific Corporation, STENTYS SA, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Cardinal Health, C. R. Bard, Inc., Meril Life Sciences Pvt. Ltd., COOK, W. L. Gore and Associates, Inc., InnoCore Technologies BV, JOTEC GmbH, Translumina, AMG International, Lombard Medical Technologies, ENDOLOGIX, INC., MIVT India, and X-Cell Medical Inc. among others.
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
Demand Side Primary Contributors: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.